abstract |
The present invention provides an ORL-1 receptor agonist with improved bioavailability by having excellent metabolic stability and stronger and higher selectivity than conventional compounds. SOLUTION: General formula (I) (In the formula, each symbol is as defined in the claims.) A compound represented by [Selection figure] None |